Bronchial histamine reactivity: its relationship to the reactivity of the bronchi to allergens
- PMID: 1016288
- DOI: 10.1111/j.1365-2222.1976.tb01937.x
Bronchial histamine reactivity: its relationship to the reactivity of the bronchi to allergens
Abstract
The aim of this study was to examine the proposal that the magnitude of the response of the bronchi to an immediate allergic reaction depends not only on the degree of sensitization of the bronchi by allergen specific IgE antibody but also on the reactivity of the bronchi to the vasoactive mediators which are released during immediate allergic reactions. This was done by determining the bronchial reactivity to Dermatophagoides pteronyssinus and to histamine of both symptomatic and asymptomatic groups of atopic subjects who had comparable serum levels of D. pteronyssinus specific IgE. Positive bronchial responses to the D. pteronyssinus extract were recorded with both the symptomatic and asymptomatic subjects, the mean bronchial threshold dose of allergen being significantly higher in the asymptomatic than in the asthmatic patients. There was a highly significant correlation between the serum level of allergen specific IgE and the bronchial threshold dose of allergen extract and also between the bronchial threshold dose of allergen extract and of histamine in all groups of subjects. The ability to predict bronchial reactivity to the allergen from the serum level of allergen specific IgE within each group was significantly better if the bronchial reactivity to histamine was included in the correlation analysis. This supports the hypothesis that whether a particular subject who is producing specific IgE antibody will develop symptoms on the inhalation of that allergen depends not only on the amount of allergen which he inhales and on the degree of sensitization of his bronchi but also on the reactivity of his bronchi to the vasoactive mediators which are released by allergen-IgE interaction.
Similar articles
-
Der p 1 and Der p 2 induce less severe late asthmatic responses than native Dermatophagoides pteronyssinus extract after a similar early asthmatic response.Clin Exp Allergy. 2001 May;31(5):705-14. doi: 10.1046/j.1365-2222.2001.01120.x. Clin Exp Allergy. 2001. PMID: 11422129 Clinical Trial.
-
Bronchial allergen challenge in subjects with low levels of allergic sensitization to indoor allergens.Allergy. 1999 Apr;54(4):366-74. doi: 10.1034/j.1398-9995.1999.00962.x. Allergy. 1999. PMID: 10371096
-
Bronchial allergen challenge with isolated major allergens of Dermatophagoides pteronyssinus: the role of patient characteristics in the early asthmatic response.J Allergy Clin Immunol. 1998 Jul;102(1):24-31. doi: 10.1016/s0091-6749(98)70051-x. J Allergy Clin Immunol. 1998. PMID: 9679844
-
Mediators and non-specific bronchial hyperreactivity.Eur J Respir Dis Suppl. 1983;129:95-111. Eur J Respir Dis Suppl. 1983. PMID: 6360702 Review.
-
[The relation between rhinitis and allergic asthma. The action of antihistaminics on bronchial hyperreactivity].Rev Mal Respir. 1995;12(2):79-85. Rev Mal Respir. 1995. PMID: 7746951 Review. French.
Cited by
-
Specific bronchoprovocation testing.Clin Rev Allergy. 1990 Summer-Fall;8(2-3):147-57. doi: 10.1007/BF02914442. Clin Rev Allergy. 1990. PMID: 2292092 Review. No abstract available.
-
Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample.Thorax. 1993 Sep;48(9):899-905. doi: 10.1136/thx.48.9.899. Thorax. 1993. PMID: 8236072 Free PMC article.
-
Antihistamines in the treatment of asthma.Clin Rev Allergy. 1994 Spring;12(1):65-78. doi: 10.1007/BF02815510. Clin Rev Allergy. 1994. PMID: 7915192 Review. No abstract available.
-
Fine-Tuning of Mast Cell Activation by FcεRIβ Chain.Front Immunol. 2012 May 16;3:112. doi: 10.3389/fimmu.2012.00112. eCollection 2012. Front Immunol. 2012. PMID: 22623922 Free PMC article.
-
Clinical expression of airway hyperreactivity in adults.Clin Rev Allergy. 1989 Fall;7(3):321-43. doi: 10.1007/BF02914481. Clin Rev Allergy. 1989. PMID: 2676136 Review. No abstract available.